Lisata Therapeutics (LSTA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
LSTA jumps 4.9% to $1.07. Closed at $1.07, +4.90% vs the prior close of $1.02. Day range $1.00–$1.07, opened at $1.05.
LSTA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LSTA jumps 4.9% to $1.07
- Closed at $1.07, +4.90% vs the prior close of $1.02. Day range $1.00–$1.07, opened at $1.05.
- Volume was 23.20K shares, 0.1x its 50-day average of 348.39K — lighter than usual.
- Price is -24.3% vs its 50-day average ($1.41) and -64.9% vs its 200-day average ($3.05).
- 52-week range $0.98–$5.07; today's close sits at 2% of that range, 78.9% below the 52-week high.
Oct 14, 2026 — LSTA slides 5.6% to $1.02, a 1-month low
- Closed at $1.02, -5.56% vs the prior close of $1.08. Day range $1.00–$1.07, opened at $1.00.
- Volume was 80.10K shares, 0.2x its 50-day average of 350.04K — lighter than usual.
- Price is -27.9% vs its 50-day average ($1.41) and -66.6% vs its 200-day average ($3.05).
- 52-week range $0.98–$5.07; today's close sits at 1% of that range, 79.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — LSTA rises 2.9% to $1.08
- Closed at $1.08, +2.86% vs the prior close of $1.05. Day range $0.99–$1.15, opened at $1.10.
- Volume was 146.90K shares, 0.4x its 50-day average of 351.60K — lighter than usual.
- Price is -23.8% vs its 50-day average ($1.42) and -64.6% vs its 200-day average ($3.05).
- 52-week range $0.98–$5.07; today's close sits at 2% of that range, 78.7% below the 52-week high.
Oct 12, 2026 — LSTA dips 0.9% to $1.05, a 1-month low
- Closed at $1.05, -0.94% vs the prior close of $1.06. Day range $0.98–$1.06, opened at $1.04.
- Volume was 166.70K shares, 0.5x its 50-day average of 349.65K — lighter than usual.
- Price is -25.9% vs its 50-day average ($1.42) and -65.7% vs its 200-day average ($3.06).
- 52-week range $0.98–$5.07; today's close sits at 2% of that range, 79.3% below the 52-week high.
Oct 9, 2026 — LSTA slides 11.7% to $1.06, a 1-month low
- Closed at $1.06, -11.67% vs the prior close of $1.20. Day range $1.02–$1.28, opened at $1.28.
- Volume was 280.20K shares, 0.8x its 50-day average of 346.14K.
- Price is -25.1% vs its 50-day average ($1.42) and -65.4% vs its 200-day average ($3.06).
- 52-week range $0.99–$5.07; today's close sits at 2% of that range, 79.1% below the 52-week high.
Oct 8, 2026 — LSTA rises 2.6% to $1.20 on 2.1x normal volume
- Closed at $1.20, +2.56% vs the prior close of $1.17. Day range $1.13–$1.31, opened at $1.22.
- Volume was 704.50K shares, 2.1x its 50-day average of 338.46K — unusually heavy trading.
- Price is -15.2% vs its 50-day average ($1.41) and -60.9% vs its 200-day average ($3.07).
- 52-week range $0.99–$5.07; today's close sits at 5% of that range, 76.3% below the 52-week high.
Oct 7, 2026 — LSTA slides 3.3% to $1.17, a 1-month low, 4 down days in a row
- Closed at $1.17, -3.31% vs the prior close of $1.21. Day range $1.16–$1.22, opened at $1.22.
- Volume was 13.60K shares, 0.0x its 50-day average of 342.47K — lighter than usual.
- Price is -17.2% vs its 50-day average ($1.41) and -61.9% vs its 200-day average ($3.07).
- 52-week range $0.99–$5.07; today's close sits at 4% of that range, 76.9% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — LSTA slides 4.0% to $1.21, a 1-month low, 3 down days in a row
- Closed at $1.21, -3.97% vs the prior close of $1.26. Day range $1.14–$1.32, opened at $1.31.
- Volume was 124.20K shares, 0.4x its 50-day average of 342.82K — lighter than usual.
- Price is -14.3% vs its 50-day average ($1.41) and -60.7% vs its 200-day average ($3.08).
- 52-week range $0.99–$5.07; today's close sits at 5% of that range, 76.1% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — LSTA slides 14.3% to $1.26, a 1-month low
- Closed at $1.26, -14.29% vs the prior close of $1.47. Day range $1.26–$1.48, opened at $1.45.
- Volume was 90.80K shares, 0.3x its 50-day average of 343.68K — lighter than usual.
- Price is -11.1% vs its 50-day average ($1.42) and -59.1% vs its 200-day average ($3.08).
- 52-week range $0.99–$5.07; today's close sits at 7% of that range, 75.1% below the 52-week high.
Oct 2, 2026 — LSTA dips 1.3% to $1.47
- Closed at $1.47, -1.34% vs the prior close of $1.49. Day range $1.47–$1.50, opened at $1.49.
- Volume was 3.70K shares, 0.0x its 50-day average of 344.69K — lighter than usual.
- Price is +3.2% vs its 50-day average ($1.42) and -52.4% vs its 200-day average ($3.09).
- 52-week range $0.99–$5.07; today's close sits at 12% of that range, 71.0% below the 52-week high.
LSTA latest news & SEC filings
Every SEC filing by or about LSTA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 7, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 28, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 28, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 3.02 — Sold unregistered shares.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 26, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $70.00K) (-100.0% vs Jun 30, 2025)
- Net income: -$2.93M (prior year -$4.66M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.32 (prior year -$0.54) (loss narrowed vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.05 — Costs tied to exiting activities / restructuring.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Jul 28, 2026 · Form SC TO-T/A — SC TO-T/A filing
SC TO-T/A filing
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jul 21, 2026 · Form SC 14D9/A — SC 14D9/A filing
SC 14D9/A filing
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 17, 2026 · Form SC 14D9/A — SC 14D9/A filing
SC 14D9/A filing
Things to know before you trade LSTA
- Last results release: Nov 6, 2025 (8-K Item 2.02). Previous ones: Aug 7, 2025, Jun 17, 2025, May 8, 2025. Based on that rhythm, the next report is likely around Feb 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.59% (largest 14.3%). That is a volatile stock.
- Liquidity: about 131.35K shares (≈$140.55K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.07 vs a range of $0.98–$5.07 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 17, 2026; 10-Q Aug 6, 2026.
- Share count: 9.01M shares outstanding (Aug 6, 2026), +2.9% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LSTA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.05 | 1.07 | 1.00 | 1.07 | 23.20K |
| Oct 14, 2026 | 1.00 | 1.07 | 1.00 | 1.02 | 80.10K |
| Oct 13, 2026 | 1.10 | 1.15 | 0.99 | 1.08 | 146.90K |
| Oct 12, 2026 | 1.04 | 1.06 | 0.98 | 1.05 | 166.70K |
| Oct 9, 2026 | 1.28 | 1.28 | 1.02 | 1.06 | 280.20K |
| Oct 8, 2026 | 1.22 | 1.31 | 1.13 | 1.20 | 704.50K |
| Oct 7, 2026 | 1.22 | 1.22 | 1.16 | 1.17 | 13.60K |
| Oct 6, 2026 | 1.31 | 1.32 | 1.14 | 1.21 | 124.20K |
| Oct 5, 2026 | 1.45 | 1.48 | 1.26 | 1.26 | 90.80K |
| Oct 2, 2026 | 1.49 | 1.50 | 1.47 | 1.47 | 3.70K |
| Oct 1, 2026 | 1.42 | 1.56 | 1.42 | 1.49 | 63.10K |
| Sep 30, 2026 | 1.47 | 1.50 | 1.44 | 1.44 | 17.10K |
| Sep 29, 2026 | 1.48 | 1.54 | 1.44 | 1.47 | 50.70K |
| Sep 28, 2026 | 1.56 | 1.57 | 1.50 | 1.50 | 38.20K |
| Sep 25, 2026 | 1.54 | 1.58 | 1.49 | 1.58 | 47.90K |
| Sep 24, 2026 | 1.47 | 1.53 | 1.44 | 1.50 | 25.50K |
| Sep 23, 2026 | 1.46 | 1.50 | 1.40 | 1.44 | 77.20K |
| Sep 22, 2026 | 1.55 | 1.60 | 1.44 | 1.48 | 152.80K |
| Sep 21, 2026 | 1.64 | 1.65 | 1.54 | 1.56 | 227.00K |
| Sep 18, 2026 | 1.71 | 1.76 | 1.61 | 1.70 | 293.70K |
About Lisata Therapeutics
Lisata Therapeutics (LSTA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BASKING RIDGE, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 320017.
LSTA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mohammad Azab | Director | Jan 13, 2026 |
| Gregory B Brown | Director | Jan 13, 2026 |
| Cynthia Louise Flowers | Director | Jan 13, 2026 |
| Heidi Henson | Director | Jan 13, 2026 |
| Steven M Klosk | Director | Jan 13, 2026 |
| Ted W Love | Director | Sep 28, 2026 |
| David J Mazzo | President & CEO | Jan 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kristen K Buck | EVP, R&D and CMO | Jan 13, 2026 |
| Tariq Imam | SVP, Bus Dev, General Counsel | Jan 13, 2026 |
| Joshua Lehrer-Graiwer | President & COO | Sep 28, 2026 |
| David J Mazzo | President & CEO | Jan 13, 2026 |
| James Nisco | SVP, Fin/Treas, Chief Actg Off | Jan 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LSTA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $170.00K | $-16.59M | -1.91 | $-15.95M |
| Dec 31, 2024 | $1.00M | $-19.98M | -2.40 | $-19.36M |
| Dec 31, 2023 | $0 | $-20.84M | -2.58 | $-20.03M |
| Dec 31, 2022 | $0 | $-54.23M | -10.47 | $-21.17M |
| Dec 31, 2021 | — | $-27.47M | -7.45 | $-22.25M |
Latest balance sheet: total assets $11.03M, total liabilities $3.04M, cash $10.44M (as of Jun 30, 2026).
LSTA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.35 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.80 |
| Jun 17, 2025 | 8-K Item 2.02 (results) | $2.40 |
| May 8, 2025 | 8-K Item 2.02 (results) | $2.37 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $2.40 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $2.91 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| Jun 27, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LSTA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.